HAL Allergy Group

Last updated
HAL Allergy
Type Private
Industry Pharmaceutical
Founded1959
FounderDr. Johan Kuijper
Headquarters Leiden Bio Science Park, Netherlands
ProductsPURETHAL, SUBLIVAC, VENOMENHAL, Provo Test
Number of employees
300
Parent Droege International Group
Website www.hal-allergy.com
One of the HAL Allergy buildings in Leiden. J.H. Oortweg 15-17 Leiden HAL.JPG
One of the HAL Allergy buildings in Leiden.

HAL Allergy Group is a pharmaceutical company that develops, produces and sells products for allergy diagnostic and allergen immunotherapy (AIT). The research facilities and headquarters are located at the Leiden Bio Science Park, Netherlands. [1]

Contents

The focus since 1959 stems from the development, production and distribution of allergen immunotherapies for the treatment and prevention of allergic diseases. These immunotherapies produced are subcutaneous (SCIT) or sublingual (SLIT) administrated and used primarily against common allergies such as hay fever, house dust mite allergy and allergic reactions towards wasp or bee stings. With offices in major European countries, HAL Allergy is one of the European top players, particularly in the field of allergy.

In addition, HAL Allergy has a specific expertise in the area of contract manufacturing with focus on the production of biopharmaceutical products for preclinical and clinical studies. This is done by its subsidiary HALIX B.V.

HAL Allergy originally stems from 'Haarlems Allergenen Laboratorium', a Dutch company set up in Haarlem. The company started as a small laboratory where, on request of several local general practitioners (GPs), extracts were prepared on a named patient basis to treat against allergic reactions.

History

HAL Allergy was established in 1959. At the time of its inception it was located in the centre of Haarlem. The name HAL Allergy comes from 'Haarlems Allergenen Laboratorium'.

The founder of HAL Allergy Johan Kuijper identified at an early stage the relevance of standardisation and stability of allergen extracts as well as being one of the initiators of the establishment of a European Clearing House [2] for allergen extracts from which the Paul Ehrlich Seminars originated.

In the 1970s, the company began exporting to Germany on larger scale. Over the years, the product portfolio has seen changes and development. In January 2007 the company moved from Haarlem to bigger premises at the Bio Science Park in Leiden in the Netherlands [3]

Aside from the development and production of allergy vaccines, HAL Allergy started a contract manufacturing organization (CMO) in 2012, named HALIX that is engaged in the production of biotechnological products for preclinical and clinical studies.

Timeline

Corporate information

HAL Allergy is a privately held company registered in The Netherlands. HAL Allergy is a part of Droege International Group AG.

The members of HAL Allergy's board of directors are: [4] [5]

Research

HAL Allergy develops and markets innovative products, that are convenient-to-use, for the treatment of respiratory, venom and food allergies.

Products

Allergy immunotherapy products account for most of HAL Allergy's ’s revenues and comprise the following types of product:

The aforementioned allergy immunotherapy products are purified from natural sources.

Sponsorships

HAL Allergy is one of the founder sponsors of the European Academy of Allergy and Clinical Immunology (EAACI). [11]

Related Research Articles

Allergy Immune system response to a substance that most people tolerate well

Allergies, also known as allergic diseases, are a number of conditions caused by hypersensitivity of the immune system to typically harmless substances in the environment. These diseases include hay fever, food allergies, atopic dermatitis, allergic asthma, and anaphylaxis. Symptoms may include red eyes, an itchy rash, sneezing, a runny nose, shortness of breath, or swelling. Food intolerances and food poisoning are separate conditions.

An allergen is a type of antigen that produces an abnormally vigorous immune response in which the immune system fights off a perceived threat that would otherwise be harmless to the body. Such reactions are called allergies.

Anaphylaxis Life-threatening allergic reaction

Anaphylaxis, often known as anaphylactic shock, is a serious, potentially fatal allergic reaction and medical emergency that is rapid in onset and requires immediate medical attention regardless of use of emergency medication on site. It typically causes more than one of the following: an itchy rash, throat closing due to swelling which can obstruct or stop breathing; severe tongue swelling which can also interfere with or stop breathing; shortness of breath, vomiting, lightheadedness, loss of consciousness, low blood pressure and medical shock. These symptoms typically start in minutes to hours and then increase very rapidly to life threatening levels. Urgent medical treatment is required to prevent serious harm or death, even if the patient has used an epipen or has taken other medications in response, and even if symptoms appear to be improving.

Allergic rhinitis Human disease

Allergic rhinitis, of which the seasonal type is called hay fever, is a type of inflammation in the nose that occurs when the immune system overreacts to allergens in the air. Signs and symptoms include a runny or stuffy nose, sneezing, red, itchy, and watery eyes, and swelling around the eyes. The fluid from the nose is usually clear. Symptom onset is often within minutes following allergen exposure, and can affect sleep and the ability to work or study. Some people may develop symptoms only during specific times of the year, often as a result of pollen exposure. Many people with allergic rhinitis also have asthma, allergic conjunctivitis, or atopic dermatitis.

Allergen immunotherapy Medical treatment for environmental allergies

Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for environmental allergies, such as insect bites, and asthma. Immunotherapy involves exposing people to larger and larger amounts of allergen in an attempt to change the immune system's response.

Jack jumper ant Species of ant

The jack jumper ant, also known as the jack jumper, jumping jack, hopper ant, or jumper ant, is a species of venomous ant native to Australia. Most frequently found in Tasmania and southeast mainland Australia, it is a member of the genus Myrmecia, subfamily Myrmeciinae, and was formally described and named by British entomologist Frederick Smith in 1858. This species is known for its ability to jump long distances. These ants are large; workers and males are about the same size: 12 to 14 mm for workers, and 11 to 12 mm for males. The queen measures roughly 14 to 16 mm long and is similar in appearance to workers, whereas males are identifiable by their perceptibly smaller mandibles.

Peanut allergy Type of food allergy caused by peanuts

Peanut allergy is a type of food allergy to peanuts. It is different from tree nut allergies, because peanuts are legumes and not true nuts. Physical symptoms of allergic reaction can include itchiness, hives, swelling, eczema, sneezing, asthma attack, abdominal pain, drop in blood pressure, diarrhea, and cardiac arrest. Anaphylaxis may occur. Those with a history of asthma are more likely to be severely affected.

Oral allergy syndrome (OAS) is a type of food allergy classified by a cluster of allergic reactions in the mouth and throat in response to eating certain fruits, nuts, and vegetables that typically develops in adults with hay fever.

Allergies to cats are one of the most common allergies among human individuals. Among the eight known cat allergens, the most prominent allergen is secretoglobin Fel d 1, and it is produced in the anal glands, salivary glands, and, mainly, in sebaceous glands of cats, and is ubiquitous in the United States, even in households without cats. Allergic symptoms associated with cats include coughing, wheezing, chest tightening, itching, nasal congestion, rash, watery eyes, sneezing, chapped lips, and similar symptoms. In worst-case scenarios, allergies to cats can develop into more life-threatening conditions such as rhinitis and mild to severe forms of asthma. Despite these symptoms, there are many types of solutions to mitigate the allergic effects of cats, including medications, vaccines, and home remedies. Hypoallergenic cats are another solution for individuals who want pets without the allergic consequences. Furthermore, prospective pet owners can reduce allergic reactions by selecting female cats, which are associated with a lower production of allergens.

Milk allergy Type of food allergy caused by milk

Milk allergy is an adverse immune reaction to one or more proteins in cow's milk. Among the possible symptoms is anaphylaxis, a potentially life-threatening condition that requires treatment with epinephrine, among other measures. However, symptoms may take hours to days to manifest, with symptoms including atopic dermatitis, inflammation of the esophagus, enteropathy involving the small intestine and proctocolitis involving the rectum and colon.

Egg allergy Type of food allergy caused by eggs

Egg allergy is an immune hypersensitivity to proteins found in chicken eggs, and possibly goose, duck, or turkey eggs. Symptoms can be either rapid or gradual in onset. The latter can take hours to days to appear. The former may include anaphylaxis, a potentially life-threatening condition which requires treatment with epinephrine. Other presentations may include atopic dermatitis or inflammation of the esophagus.

ALK-Abelló A/S, also commonly known as ALK, is a Denmark-based pharmaceutical company which specializes in the development and manufacture of allergy immunotherapy (AIT) products for the prevention and treatment of allergy. It is one of the world’s largest makers of allergy immunotherapy products with 81% of its revenue coming from sales in Europe.

Enzyme potentiated desensitization (EPD), is a treatment for allergies developed in the 1960s by Dr. Leonard M. McEwen in the United Kingdom. EPD uses much lower doses of antigens than conventional desensitization treatment paired with the enzyme β-glucuronidase. EPD is approved in the United Kingdom for the treatment of hay fever, food allergy and intolerance and environmental allergies.

Torsten Zuberbier is a German dermatologist and allergologist.

Stallergenes Greer

Stallergenes Greer Ltd is a global biopharmaceutical company headquartered in London, specializing in the diagnosis and treatment of respiratory allergies through immunotherapy.

William Frankland (allergist) British immunologist

Alfred William Frankland MBE was a British allergist and immunologist whose achievements included the popularisation of the pollen count as a piece of weather-related information to the British public, speculation regarding the effects of overly sterile living environments, and the prediction of increased levels of allergy to penicillin. He continued to work for a number of years after turning 100.

Ursula Wiedermann is an Austrian medical scientist who has made significant contributions in the field of allergies and of cancer immunotherapy. She is currently Professor of Vaccinology at the Medical University of Vienna. Wiedermann's work in the field of B cell peptide vaccines led to the creation of HER-Vaxx, an immunotherapy for the treatment of HER-2-positive cancers. This vaccine is currently being taken into mid-stage clinical development in gastric cancer by the biotech company Imugene, where Wiedermann is Chief Scientific Officer.

Dust mite allergy Medical condition

Dust mite allergy, also known as house dust allergy, is a sensitization and allergic reaction to the droppings of house dust mites. The allergy is common and can trigger allergic reactions such as asthma, eczema or itching. It is the manifestation of a parasitosis. The mite's gut contains potent digestive enzymes that persist in their feces and are major inducers of allergic reactions such as wheezing. The mite's exoskeleton can also contribute to allergic reactions. Unlike scabies mites or skin follicle mites, house dust mites do not burrow under the skin and are not parasitic.

Giorgio Walter Canonica Italian allergist and pulmonologist

Giorgio Walter Canonica is an Italian allergist, pulmonologist and professor of Respiratory Medicine at Humanitas University, Milan, Italy and Director Personalized Medicine Asthma & Allergy Center at Humanitas Research Hospital IRCCS-Milano Italy since December 2016. He is known for his research work related to innovative treatment strategies for allergic diseases which includes biological response modifier in form of targeted immunotherapy with primary emphasis on sublingual immunotherapy (SLIT). He has served as Secretary General and President elect of World Allergy Organisation for six consecutive years and has served as president of the same organization during 2007–09. He is also the vice-president of INTERASMA.

Shellfish allergy Type of food allergy caused by shellfish

Shellfish allergy is among the most common food allergies. "Shellfish" is a colloquial and fisheries term for aquatic invertebrates used as food, including various species of molluscs such as clams, mussels, oysters and scallops, crustaceans such as shrimp, lobsters and crabs, and cephalopods such as squid and octopus. Shellfish allergy is an immune hypersensitivity to proteins found in shellfish. Symptoms can be either rapid or gradual in onset. The latter can take hours to days to appear. The former may include anaphylaxis, a potentially life-threatening condition which requires treatment with epinephrine. Other presentations may include atopic dermatitis or inflammation of the esophagus. Shellfish is one of the eight common food allergens, responsible for 90% of allergic reactions to foods: cow's milk, eggs, wheat, shellfish, peanuts, tree nuts, fish, and soy beans.

References

  1. "Leiden Bio Science Park's website" . Retrieved 2016-03-06.
  2. Kurth, Reinhard; Siefert, Gerhard, eds. (1990). Regulatory Control and Standardization of Allergenic Extracts. Frankfurt A.M.: Gustav Fischer. p. 1. ISBN   978-1560813262.
  3. Fighting the cause of allergies, EMB News 2011
  4. "HAL Allergy's website".
  5. "Bloomberg's website".
  6. "HAL-MPE1 First-in-human - Full Text View - ClinicalTrials.gov". clinicaltrials.gov. Retrieved 2016-05-26.
  7. "SUBLIVAC FIX Birch Phase III Short-term Efficacy - Full Text View - ClinicalTrials.gov". clinicaltrials.gov. Retrieved 2016-05-26.
  8. "Sublingual Immunotherapy (SLIT), American College of Allergy, Asthma & Immunology's website" . Retrieved 2016-03-06.
  9. "Sublingual vaccines, HAL Allergy's website" . Retrieved 2016-03-06.
  10. "Subcutaneous vaccines, HAL Allergy website" . Retrieved 2016-03-06.
  11. "EAACI website" . Retrieved 2016-03-06.